Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Early treatment with Ocrevus may help protect the cerebellum from damage in people with multiple sclerosis, a study found.

Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq) is a prescription drug that’s used to treat certain forms of multiple sclerosis (MS). Ocrevus Zunovo comes as a ...

Assessing multiple sclerosis (MS) disease activity using ... called MoonStone (NCT06564311), is open to… Less frequent Ocrevus (ocrelizumab) infusions are as effective as standard dosing ...

By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...

Some research suggests there is a connection between migraines and multiple sclerosis (MS), as the conditions often co-occur. Further, the symptoms of MS may also be similar to or confused with a ...

Anti-CD20 agents: B lymphocyte depletion: Rituximab no longer being pursued for multiple sclerosis (MS) indication. Ocrelizumab Phase II with positive results, several Phase III underway.

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS ... Roche's first-to-market anti-CD20 drug Ocrevus (ocrelizumab), even though that drug needs to be administered ...

Having higher numbers of particular gut microbes might put you at a higher risk of developing multiple sclerosis (MS), a new twin study shows. The finding could lead to new treatments for preventing ...